PsychiatryNews.net

Psychiatry Xagena

Xagena Mappa
Medical Meeting
Pneumobase.it
Mediexplorer.it

BOLDER II study confirms therapeutic potential of Seroquel in major depressive episodes associated with bipolar disorder


Results from the BOLDER II ( BipOLar DepRession ) study have underlined the potential for Seroquel ( Quetiapine ) in the treatment of patients with major depressive episodes associated with bipolar disorder.

In BOLDER II, Seroquel 300mg and 600mg doses achieved a statistically significant reduction in levels of bipolar depression compared with placebo ( p


Indietro